Alignment Healthcare, Inc.
NASDAQ:ALHCMedical - Healthcare Plans
+$0.48 today
- Market cap
- $1.41B
- Beta
- 1.15
- P/E (TTM)
- 227.0
- EPS (TTM)
- $0.10
Volume 6.79M
Average 5.33M
ALHC Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Alignment Healthcare, Inc.NASDAQ: ALHC
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns positive
Q1 FY2026 net income was $11.42M, compared with -$9.35M a year earlier. Trailing-twelve-month net income was $19.79M. Over 3 fiscal years it compounded at -83.1% a year.
Context
- Net income amounted to 0.0% of revenue in FY2025, down 4.7 pp from a year earlier.
- Net income grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 10 analysts of $9.86M (+1462.5%) for the fiscal year ending Dec 2026, a step up from the -99.4% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $11.42M+203.7% QoQ
- Last fiscal yearDec 2025
- -$724K-99.4% YoY
- LTMMar 2026
- $19.79M+121.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +222.0% | +71.9% | -150.1 pp |
| 1 year | -99.4% | +1462.5% | +1562.0 pp |
| 3-year CAGR | -83.1% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (724K) USD
- Year-over-year change
- +99.4%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (724K) | +99.4% |
| FY2024 | 2024-12-31 | (128.07M) | +13.6% |
| FY2023 | 2023-12-31 | (148.17M) | +1.0% |
| FY2022 | 2022-12-31 | (149.64M) | +23.4% |
| FY2021 | 2021-12-31 | (195.29M) | — |
Net Income vs competitors
How ALHC compares with its peers on the latest reported figures
- ALHC's LTM Mar 2026 net income of $19.79M is the smallest of the 7 companies compared; the peer median is $896.47M.
- Its year-over-year change of +121.8% is the 2nd highest of 7, against a peer median of -7.9%.
- Net income amounts to 0.5% of revenue for ALHC, versus a peer median of 2.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $16.67B | -8.1% | -14.0% | 3.7% | |
| LTM Jun 2026 | $5.11B | -350.3% | — | 2.6% | |
| LTM Sep 2026 | $5.1B | -7.7% | -2.0% | 2.5% | |
| LTM Sep 2026 | $1.24B | -3.9% | -24.6% | 0.8% | |
| LTM Jun 2026 | $550.93M | +443.4% | -10.1% | 3.6% | |
| LTM Sep 2026 | $48M | -105.4% | -15.8% | 0.1% | |
| LTM Mar 2026 | $19.79M | +121.8% | -83.1% | 0.5% | |
| Peer median (excluding ALHC) | $896.47M | -7.9% | -14.0% | 2.6% | |
Competitors are the stored peer set for ALHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (195.29M) | (149.64M) | (148.17M) | (128.07M) | (724K) |
| Depreciation & Amortization | 16.03M | 17.49M | 21.67M | 27.06M | 31.61M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 110.6M | 81.72M | 66.84M | 71.13M | 62.08M |
| Change in Working Capital | (19.42M) | (5.55M) | 2.03M | 60.89M | 35.14M |
| Accounts Receivables | (17.61M) | (34.38M) | (26.95M) | (34.28M) | (100.11M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 437K | 13.74M | (6.35M) | (1.46M) | 0 |
| Other Working Capital | (2.25M) | 15.08M | 35.32M | 96.63M | 135.25M |
| Other Non-Cash Items | 9.29M | 10.56M | (1.54M) | 3.76M | 11.82M |
| Operating Cash Flow | (78.78M) | (45.43M) | (59.19M) | 34.77M | 139.93M |
| Capital Expenditures | (18.36M) | (23.77M) | (36M) | (41.42M) | (26.78M) |
| Acquisitions (Net) | 0 | (4.04M) | 0 | 0 | 1.14M |
| Purchases of Investments | (2.48M) | (2.83M) | (379.06M) | (82.2M) | (65.63M) |
| Sales of Investments | 1.43M | 2.43M | 267.79M | 162.8M | 76.3M |
| Other Investing Activities | (1.41M) | 0 | 0 | 14K | 0 |
| Investing Cash Flow | (20.82M) | (28.22M) | (147.26M) | 39.19M | (14.97M) |
| Debt Repayment | 0 | 21.82M | 0 | 165M | 0 |
| Common Stock Issued | 390.6M | 0 | 0 | 0 | 18.07M |
| Common Stock Repurchased | (1.47M) | 0 | 0 | (350K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (29M) | (5.23M) | 105K | (8.62M) | (26K) |
| Financing Cash Flow | 360.13M | 16.59M | 105K | 156.03M | 18.04M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 260.54M | (57.05M) | (206.35M) | 229.99M | 142.99M |
| Free Cash Flow | (97.14M) | (69.2M) | (95.18M) | (6.65M) | 113.15M |
Alignment Healthcare, Inc.
NASDAQ:ALHC
Intrinsic Alpha fair value
Locked
Current Price
$6.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.